Compounds > carbenoxolone sodium
Page last updated: 2024-08-24

carbenoxolone sodium and omeprazole

carbenoxolone sodium has been researched along with omeprazole in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19906 (85.71)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guslandi, M1
Bank, S1
Hunt, RH; Jones, DB1
Misiewicz, JJ1
Demling, L1
Levine, JB1
de Melo, IL; de Oliveira e Silva, AM; Farsky, SH; Machado, ID; Mancini-Filho, J; Santin, JR; Shimoyama, AT1

Reviews

3 review(s) available for carbenoxolone sodium and omeprazole

ArticleYear
Ulcer-healing drugs and endogenous prostaglandins.
    International journal of clinical pharmacology, therapy, and toxicology, 1985, Volume: 23, Issue:8

    Topics: Aluminum; Animals; Anti-Ulcer Agents; Benzimidazoles; Benzodiazepinones; Carbenoxolone; Cimetidine; Gastric Acid; Humans; Omeprazole; Peptic Ulcer; Pirenzepine; Prostaglandins; Ranitidine; Somatostatin; Stimulation, Chemical; Sucralfate

1985
Medical management of peptic ulcer.
    Postgraduate medical journal, 1984, Volume: 60, Issue:709

    Topics: Aluminum; Antacids; Benzimidazoles; Bismuth; Carbenoxolone; Cimetidine; Duodenal Ulcer; Humans; Omeprazole; Parasympatholytics; Ranitidine; Recurrence; Stomach Ulcer; Sucralfate; Time Factors

1984
Pharmacologic options for the control of peptic ulcer disease.
    Advances in internal medicine, 1984, Volume: 30

    Topics: Antacids; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Carbenoxolone; Cimetidine; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Omeprazole; Parasympatholytics; Peptic Ulcer; Prostaglandins, Synthetic; Ranitidine; Risk; Stomach Neoplasms; Surface-Active Agents

1984

Other Studies

4 other study(ies) available for carbenoxolone sodium and omeprazole

ArticleYear
Stress ulcers--prevention of gastrointestinal bleeding in critical care units.
    The Medical journal of Australia, 1985, Feb-04, Volume: 142 Spec No

    Topics: Aluminum; Antacids; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Carbenoxolone; Critical Care; Gastritis; Histamine H2 Antagonists; Humans; Omeprazole; Organometallic Compounds; Peptic Ulcer Hemorrhage; Prostaglandins; Risk; Stomach Ulcer; Stress, Physiological; Sucralfate

1985
The drug treatment of duodenal ulcer: physiological considerations in the choice of therapy.
    Australian and New Zealand journal of medicine, 1986, Volume: 16, Issue:2

    Topics: Aluminum; Antacids; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Carbenoxolone; Dinoprostone; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Intestinal Mucosa; Omeprazole; Organometallic Compounds; Parasympatholytics; Prostaglandins E; Sucralfate; Trimipramine

1986
[Changes in therapy of duodenal ulcers. The European Gastro-Club 1983 discusses new pathophysiologic and epidemiologic data referring to drug and surgical therapy].
    Fortschritte der Medizin, 1983, Dec-15, Volume: 101, Issue:47-48

    Topics: Amino Acids; Benzimidazoles; Carbenoxolone; Cimetidine; Duodenal Ulcer; Gastric Acid; Histamine; Histamine H2 Antagonists; Humans; Omeprazole; Ranitidine; Stomach Neoplasms

1983
Antiulcerogenic activity of chlorogenic acid in different models of gastric ulcer.
    Naunyn-Schmiedeberg's archives of pharmacology, 2013, Volume: 386, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Carbenoxolone; Chlorogenic Acid; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Male; Mice; Omeprazole; Stomach Ulcer; Time Factors

2013